Chronic constipation is one of the most frequent GI diagnoses in ambulatory medicine clinics, and often results in referrals to gastroenterologists. In this webcast, national gastroenterology experts review the diagnosis of chronic constipation, differentiating between irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC), and provide recommendations for nonpharmacologic and pharmacologic strategies to improve patient outcomes.
In Collaboration With:
Interactive video lecture
After completing this activity, participants should be better able to:
- Apply a guideline-recommended approach to the diagnosis of IBS-C and CIC, including appropriate testing
- Utilize recommended nonpharmacologic strategies for the management of IBS-C and CIC
- Select therapies for IBS-C and CIC based on efficacy and safety evidence and guideline recommendations
NPs and PAs specializing in gastroenterology
Joint Accreditation Statement
In support of improving patient care, Practicing Clinicians Exchange is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
ANCC Credit Designation
Nursing contact hours: 1.50, which includes 1.50 hours of pharmacology credit
AAPA Credit Designation
Practicing Clinicians Exchange has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.50 AAPA Category 1 CME credits. Approval is valid until June 26, 2023. PAs should only claim credit commensurate with the extent of their participation.
PA course advisor: Richard H. Davis, PA-C, University of Florida College of Medicine, Gainesville, Florida
IPCE Credit Designation
This activity was planned by and for the healthcare team, and learners will receive 1.50 Interprofessional Continuing Education (IPCE) credits for learning and change.
This activity is supported by educational grants from AbbVie Inc. and Ironwood Pharmaceuticals; and Salix Pharmaceuticals.
The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Practicing Clinicians Exchange or any educational supporter.
All faculty and planners participating in continuing education activities sponsored by Practicing Clinicians Exchange (PCE) are required to disclose all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PCE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
William Chey, MD: consultant/advisor/speaker: AbbVie, Allakos, Alnylam, Ardelyx, Arena, Bayer, Biomerica, Ironwood, Nestle, Salix/Valeant, Takeda, Urovant Sciences, Vibrant; researcher/consultant/advisor/speaker: QOL Medicine; researcher: Commonwealth, Salix.
Kimberly Kearns, MS, APRN, ANP-BC: consultant/advisor/speaker: Bristol-Myers Squibb, Eli Lilly, Janssen, Medtronic, Salix, Takeda.
Monica Nandwani, DNP, RN, FNP-BC: consultant/advisor/speaker: Phathom Pharmaceuticals.
None of the members of the Planning Committee or PCE staff have any relevant financial relationships to disclose.
Participants wishing to earn CE/CME credit must:
- View the content in its entirety
- Relate the content material to the learning objectives
- Complete the evaluation form
The estimated time to complete this activity is 1.50 hours.
Release date: June 27, 2022
Expiration date: June 26, 2023
© 2022 Practicing Clinicians Exchange. All Rights Reserved. 104421GABC-WC1